CY1116193T1 - TRANS-NORSERTRALINE PREPARATIONS, SALTS AND POLYMORPHIC FORMS AND THEIR USES - Google Patents

TRANS-NORSERTRALINE PREPARATIONS, SALTS AND POLYMORPHIC FORMS AND THEIR USES

Info

Publication number
CY1116193T1
CY1116193T1 CY20151100226T CY151100226T CY1116193T1 CY 1116193 T1 CY1116193 T1 CY 1116193T1 CY 20151100226 T CY20151100226 T CY 20151100226T CY 151100226 T CY151100226 T CY 151100226T CY 1116193 T1 CY1116193 T1 CY 1116193T1
Authority
CY
Cyprus
Prior art keywords
trans
salts
norsertraline
preparations
polymorphic forms
Prior art date
Application number
CY20151100226T
Other languages
Greek (el)
Inventor
Sharon M Laughlin
Michael J Sizensky
Surendra P Singh
Scott H Wilkinson
Cai Gu Huang
Philip James Bonasia
Susan S D'souza
Original Assignee
Sunovion Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP10835166.9A external-priority patent/EP2506842B1/en
Application filed by Sunovion Pharmaceuticals Inc. filed Critical Sunovion Pharmaceuticals Inc.
Publication of CY1116193T1 publication Critical patent/CY1116193T1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Παρέχονται στο παρόν φαρμακευτικές συνθέσεις οι οποίες περιλαμβάνουν trans-νορσερτραλίνη, άλατα και πολυμορφικές μορφές της trans-νορσερτραλίνης, μέθοδοι παρασκευής των συνθέσεων, και μέθοδοι για τη χρήση του για την αντιμετώπιση νόσων του ΚΝΣ, περιλαμβάνοντας κατάθλιψη.There are provided herein pharmaceutical compositions which include trans-norsetralin, salts and polymorphs of trans-norsetralin, methods of preparing the compositions, and methods for its use in the treatment of CNS diseases, including depression.

CY20151100226T 2009-12-04 2015-03-03 TRANS-NORSERTRALINE PREPARATIONS, SALTS AND POLYMORPHIC FORMS AND THEIR USES CY1116193T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26686409A 2009-12-04 2009-12-04
EP10835166.9A EP2506842B1 (en) 2009-12-04 2010-12-03 Formulations, salts and polymorphs of transnorsertraline and uses thereof

Publications (1)

Publication Number Publication Date
CY1116193T1 true CY1116193T1 (en) 2017-02-08

Family

ID=58457977

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20151100226T CY1116193T1 (en) 2009-12-04 2015-03-03 TRANS-NORSERTRALINE PREPARATIONS, SALTS AND POLYMORPHIC FORMS AND THEIR USES

Country Status (1)

Country Link
CY (1) CY1116193T1 (en)

Similar Documents

Publication Publication Date Title
CY1120318T1 (en) Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperplasia patients
CY1121858T1 (en) ARYLMETHOXY ISOINDOLINE DERIVATIVES AND COMPOSITIONS CONTAINING THEM AND METHODS OF USING THEM
CY1121694T1 (en) BICYCLIC-FUSED HETEROARYL OR ARYL COMPOUNDS AND THEIR USE AS IRAK4 INHIBITORS
CY1118819T1 (en) HETROCYCLE UNIONS IP HOLDING AGENTS
CY1117615T1 (en) THEIAZOLIS SULFONAMIDIS AND OXAZOLIS COMPOUNDS
CY1119974T1 (en) SOLID FORMS 3- (5-AMINO-2-Methyl-4-oxo-4H-quinazolin-3-yl) -piperidine-2,6-dionyses and pharmaceutical compositions and uses
CY1121742T1 (en) S100A4 ANTIBODIES AND THERAPEUTIC USES THEREOF
CY1115502T1 (en) DISEASE STAGING FACTORS FOR CANCER AND IMMUNE AND IMMUNE DISEASES
CY1118662T1 (en) NEW BICYCLE PYRIDINONS
CY1117423T1 (en) FACTORS AFFECTING CANCER AND IMMUNE AND IMMUNE DISEASES
CL2009000349A1 (en) Compounds derived from 4,5-dihydro-oxazol-2-ylamine; preparation procedure; pharmaceutical composition; and its use for the treatment of Alzheimer's disease.
CY1117584T1 (en) 1-Benzyl-3-hydroxymethyldazole derivative and their use in the therapeutic treatment of MCP-1-expressing MC3-C3
CY1113924T1 (en) CARVASOLIS UNITS AND THERAPEUTIC USE OF UNITS
EA201270722A1 (en) RIFAXIMINE FORMS AND THEIR APPLICATION
EA201170872A1 (en) PROTEINKINASE INHIBITORS
CY1112558T1 (en) N -MYTHYLAMINOMETHYL METHYL COMPOUNDS AND COMPOSITIONS INCLUDING THEIR METHODS OF USE
CY1117105T1 (en) PYRIDAZINONIN COMPOUNDS AND USE AS DAAO SUSPENSIONS
CY1117504T1 (en) 1-Benzyl-3-hydroxymethyldazole derivative and their use in the therapeutic treatment of MCP-1 and MCP-1-expressing diseases
CY1119108T1 (en) MAGNED PYRROL DICROXOXAMIDES AND THEIR USE AS PHARMACEUTICAL PRODUCTS
UY31860A (en) PIRIDINES OF TIAZOLO AS INHIBITORS OF THE GIRASA DNA
IT1391866B1 (en) INJECTIONABLE COMPOSITION OF POLYNUCLEOTIDS FOR THE TREATMENT OF OSTEOARTICULAR DISEASES.
EA201391171A1 (en) RIFAXIMINE FORMS AND THEIR APPLICATION
CY1120133T1 (en) Pyridazines as DAAO Enzyme Inhibitors
CY1116840T1 (en) USE 24-NORUDCA
CY1120395T1 (en) STEROLIS PRODUCERS AND USE OF THESE FOR THE TREATMENT OF DISEASES CONCLUDING TRANSFORMED STRUCTURES OR FOR THE TREATMENT OF BLOODY BLOOD